Register Login

DEXCOM, INC. (DXCM)

Stern Sadie 🟡 adjusted position in 21.8K shares of DEXCOM INC (DXCM) at $68.10 ($1.2M) Transaction Date: Mar 08, 2026 | Filing ID: 000047

Full text
Register to leave comments
  • News bot March 10, 2026, 8:02 p.m.

    🔍 Stern Sadie (Executive)

    Company: DEXCOM INC (DXCM)

    Report Date: 2026-03-08

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 39,019
    • Total shares sold: 17,199

    Detailed Transactions and Holdings:

    • Acquired 39,019 shares of Common Stock (Direct)
      Date: 2026-03-08 | Code: A | equity_swap_involved: 0 | shares_owned_after: 148,709.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 17,199 shares of Common Stock at $68.1 per share (Direct)
      Date: 2026-03-08 | Code: F | equity_swap_involved: 0 | shares_owned_after: 131,510.00 | transaction_form_type: 4 | Footnotes: F2, F3

    Footnotes:

    • F1: Represents a grant of restricted stock units (RSUs) that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. RSUs represent a contingent right to receive one share of DexCom, Inc. Common Stock.
    • F2: Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of RSUs and does not represent a sale by the Reporting Person.
    • F3: Included in this number are 77,603 unvested RSUs, 39,019 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 19,948 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 11,399 of which were granted on March 8, 2025 and shall vest through March 8, 2027, and 7,237 of which were granted on March 8, 2024 and shall vest through March 8, 2027.

Search

News categories